Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Examine the ability of thymopentin (Timunox) to:
Reduce the amount and/or frequency of virus isolation. Stimulate the immune system and alter
the clinical findings in patients infected with HIV who do not yet have AIDS.